Associate Professor, Medicine, University of Washington School of Medicine
Oncology
Dr. Edus H. Warren III, MD
|
|
Give Review
Edus Warren works in the field of Oncology. Edus H. Warren III, MD has written publications. He has 44 publications published with PubMed. The lastest paper is: 'HLA-F and MHC-I Open Conformers Cooperate in a MHC-I Antigen Cross-Presentation Pathway.' Edus H. Warren III accepts Medicare.
Publications
- Toward eliminating HLA class I expression to generate universal Cells from allogeneic donors.
- HLA-F and MHC-I Open Conformers Cooperate in a MHC-I Antigen Cross-Presentation Pathway.
- High-throughput sequencing of B- and T-lymphocyte antigen receptors in hematology.
- Dissecting graft-versus-Leukemia from graft-versus-host-disease using novel strategies.
- CD8+ T-Cell Clones Specific for the 5T4 Antigen Target Renal Cell Carcinoma Tumor-initiating Cells in a Murine Xenograft Model.
- Applications of next-generation sequencing to blood and marrow transplantation.
- Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic Cell transplantation.
- Blazing a trail in T-Cell recognition.
- Activation and Expansion of CD8(+) T Effector Cells in Patients with Chronic Graft-versus-Host Disease.
- Comparative analysis of risk factors for Acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus...
- A Phase I/II Study of Chemotherapy Followed by Donor Lymphocyte Infusion plus Interleukin-2 for Relapsed Acute Leukemia after Allogeneic Hematopoietic Cell Transplanta...
- Graft versus Leukemia reactivity after allogeneic stem cell transplantation.
- Defining genetic risk for graft-versus-host disease and mortality following allogeneic hematopoietic stem Cell transplantation.
- Overlap and effective size of the human CD8+ T Cell receptor repertoire.
- Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells.
- Therapy of relapsed Leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens.
- Donor-recipient mismatch for common gene deletion polymorphisms in Graft-versus-host disease.
- Comprehensive assessment of T-Cell receptor beta-chain diversity in alphabeta T Cells.
- Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic Leukemia.
- Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem Cell transplants.
- Improving hematopoietic Cell transplant outcomes in a new era of genomic research.
- C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T Cells from renal Cell carcinoma patients.
- DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem Cells.
- A single minor histocompatibility antigen encoded by UGT2B17 and presented by human leukocyte antigen-A*2902 and -B*4403.
- An antigen produced by splicing of noncontiguous peptides in the reverse order.
- The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid Cells and B-CLL.
- Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoiet...
- Adoptive transfer of allogeneic antigen-specific T Cells.
- A novel HLA-A*3303-restricted minor histocompatibility antigen encoded by an unconventional open reading frame of human TMSB4Y gene.
- Allogeneic hematopoietic Cell transplantation for metastatic renal Cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological r...
- Female donors contribute to a selective graft-versus-Leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants.
- A human minor histocompatibility antigen resulting from differential expression due to a gene deletion.
- Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem Cell transplantation from related and unrelated donors in patients with myelodysplastic s...
- Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia: Relapse-Free Survival is Determined by Karyotype and Comorbidities.
- Allogeneic hematopoietic Cell transplantation for renal Cell carcinoma: ten years after.
- Abnormalities of the alphabeta T-Cell receptor repertoire in advanced myelodysplastic syndrome.
- Allogeneic hematopoietic stem Cell transplantation for myelofibrosis.
- Treatment change as a predictor of outcome among patients with classic Chronic graft-versus-host disease.
- Reduced incidence of Acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.
- Disparity for a newly identified minor histocompatibility antigen, HA-8, correlates with Acute graft-versus-host disease after haematopoietic stem cell transplantation...
- Evaluation of NIH consensus criteria for classification of late Acute and chronic GVHD.
- The graft versus Leukemia response after allogeneic hematopoietic stem cell transplantation.
- Genetic risk for colitis-associated coloRectal cancer.
Schools
Harvard Medical School
Massachusetts General Hospital
University Of Washington School Of Medicine
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Basal Cell Carcinoma
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
University of Washington -
Massachusetts General Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Thomas R. Chauncey, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Heather H. Cheng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marco B. Mielcarek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric Y. Chen, MD |